Veracyte reported $8.02M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Agenus USD 58.98M 12.1M Jun/2026
Agilent USD 615M 13M Mar/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
Bruker USD 200.2M 68.9M Jun/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Illumina USD 230M 12M Jun/2026
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Laboratory Of America USD 688.5M 7.2M Jun/2026
Ligand Pharmaceuticals USD 9.4M 27.7M Jun/2026
Myriad Genetics USD 30.4M 2.2M Jun/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Siemens EUR 9.3B 352M Jun/2026
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Veracyte USD 8.02M 1.12M Jun/2026
Waters USD 602M 498.22M Mar/2026